How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes
- PMID: 31216099
- DOI: 10.1002/jgc4.1143
How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes
Abstract
When a genetic disease-causing variant causing autosomal dominant diseases is identified, predictive DNA testing is possible for at-risk relatives to investigate whether they are carrying the familial variant. In current practice, the proband is asked to inform at-risk relatives, often supported by a family letter. This review summarizes the literature on preferences of probands and relatives regarding how and by whom at-risk relatives should be informed. A search involving digital databases (Pubmed, Medline, and PsycInfo) focusing on patient attitudes toward informing relatives at risk of autosomal dominant onco-, cardio-, or neurogenetic disease, resulted in 1,431 screened records, of which 117 full-text papers were assessed. Eventually, 32 studies were selected. This review shows that a majority of participants was in favor of someone in the family to inform their at-risk relatives, with participants generally feeling responsible for informing relatives at risk themselves. However, variation in patient preferences regarding who should inform was observed. Face-to-face disclosure by the proband with additional information material for relatives provided by HCPs was most appreciated. Actively offered support of healthcare professionals was desired. In conclusion, although the family-mediated approach was appreciated by a majority of participants, support by healthcare professionals was desired. By taking patient attitudes into account, the approach used to inform at-risk relatives could be improved. Subsequently, more relatives will be informed and enabled to attend genetic counseling and make an informed decision regarding predictive DNA testing. Further research on patient attitudes, specifying for disease type and cultural background, is needed.
Keywords: attitudes; autosomal dominant; carrier testing; cascade testing; communication; education; family; genetic counseling; genetic counselors; genetic testing; genetics services; hereditary disease; informing relatives; patient attitudes; service delivery models; systematic review.
© 2019 National Society of Genetic Counselors.
Similar articles
-
How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.J Genet Couns. 2020 Oct;29(5):786-799. doi: 10.1002/jgc4.1206. Epub 2019 Dec 30. J Genet Couns. 2020. PMID: 31889383 Free PMC article.
-
Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counselees.Eur J Hum Genet. 2019 Sep;27(9):1341-1350. doi: 10.1038/s41431-019-0410-9. Epub 2019 May 3. Eur J Hum Genet. 2019. PMID: 31053782 Free PMC article.
-
A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.BMJ Open. 2019 Jul 9;9(7):e025660. doi: 10.1136/bmjopen-2018-025660. BMJ Open. 2019. PMID: 31289060 Free PMC article.
-
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.Fam Cancer. 2024 Jun;23(2):155-164. doi: 10.1007/s10689-023-00356-x. Epub 2024 Jan 6. Fam Cancer. 2024. PMID: 38184510 Free PMC article. Review.
-
The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.Fam Cancer. 2019 Jan;18(1):127-135. doi: 10.1007/s10689-018-0089-z. Fam Cancer. 2019. PMID: 29846880
Cited by
-
Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives.Mov Disord Clin Pract. 2024 Jul;11(7):786-794. doi: 10.1002/mdc3.14043. Epub 2024 Apr 8. Mov Disord Clin Pract. 2024. PMID: 38586948 Free PMC article.
-
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden.Hered Cancer Clin Pract. 2020 Sep 15;18:18. doi: 10.1186/s13053-020-00151-0. eCollection 2020. Hered Cancer Clin Pract. 2020. PMID: 32944097 Free PMC article.
-
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.Eur J Hum Genet. 2024 Apr;32(4):448-455. doi: 10.1038/s41431-024-01544-8. Epub 2024 Feb 2. Eur J Hum Genet. 2024. PMID: 38308085 Free PMC article. Clinical Trial.
-
Features of Multiple Endocrine Neoplasia Type 1 and 2A in a Patient with Both RET and MEN1 Germline Mutations.J Endocr Soc. 2020 Feb 18;4(4):bvaa020. doi: 10.1210/jendso/bvaa020. eCollection 2020 Apr 1. J Endocr Soc. 2020. PMID: 32190804 Free PMC article.
-
Disclosure of genetic information to family members: a systematic review of normative documents.Genet Med. 2021 Nov;23(11):2038-2046. doi: 10.1038/s41436-021-01248-0. Epub 2021 Jul 7. Genet Med. 2021. PMID: 34234303
References
REFERENCES
-
- Aktan-Collan, K., Haukkala, A., Pylvanainen, K., Jarvinen, H. J., Aaltonen, L. A., Peltomaki, P., … Mecklin, J.-P.(2007). Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. Journal of Medical Genetics, 44( 11), 732 - 738. https://doi.org/10.1136/jmg.2007.051581
-
- Aktan-Collan, K. I., Kaariainen, H. A., Kolttola, E. M., Pylvanainen, K., Jarvinen, H. J., Haukkala, A. H., & Mecklin, J. P. (2011). Sharing genetic risk with next generation: Mutation-positive parents' communication with their offspring in Lynch Syndrome. Familial Cancer, 10(1), 43-50. https://doi.org/10.1007/s10689-010-9386-x
-
- Allison, M. (2015). Communicating risk with relatives in a familial hypercholesterolemia cascade screening program: A summary of the evidence. Journal of Cardiovascular Nursing, 30(4), E1-E12. https://doi.org/10.1097/JCN.0000000000000153
-
- Bernhardt, B. A., Zayac, C., & Pyeritz, R. E. (2011). Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Genetics in Medicine, 13(9), 812-820. https://doi.org/10.1097/GIM.0b013e31821d2e6d
-
- Blandy, C., Chabal, F., Stoppa-Lyonnet, D., & Julian-Reynier, C. (2003). Testing participation in BRCA1/2-positive families: Initiator role of index cases. Genetic Testing, 7(3), 225-233. https://doi.org/10.1089/109065703322537241
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical